Increased prevalence of mood disorders and suicidal ideation in type 2 diabetic patients (Q44324889)

2 December 2017

Increased prevalence of mood disorders and suicidal ideation in type 2 diabetic patients (English)

1 reference

2 December 2017

0 references

0 references

0 references

0 references

1 reference

10

1 reference

2 December 2017

Luciane B Ceretta

1

1 reference

2 December 2017

Gislaine Z Réus

2

1 reference

2 December 2017

Helena M Abelaira

3

1 reference

2 December 2017

Luciano K Jornada

4

1 reference

2 December 2017

Magada T Schwalm

5

1 reference

2 December 2017

Neiva J Hoepers

6

1 reference

2 December 2017

Cristiane D Tomazzi

7

1 reference

2 December 2017

Karina G Gulbis

8

1 reference

2 December 2017

Renan A Ceretta

9

1 reference

2 December 2017

11 October 2012

1 reference

2 December 2017

1 reference

2 December 2017

49 Suppl 1

1 reference

2 December 2017

S227-34

1 reference

https://scigraph.springernature.com/pub.10.1007/s00592-012-0435-9

2 December 2017

0 references

cites work

Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Genetic and clinical characteristics of maturity-onset diabetes of the young

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

A review of exenatide as adjunctive therapy in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Epidemiology, treatment and costs of depression in adults with Type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

The prevalence of co-morbid depression in adults with Type 1 diabetes: systematic literature review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Increased oxidative stress and imbalance in antioxidant enzymes in the brains of alloxan-induced diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Brain energy metabolism parameters in an animal model of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Impact of mitochondrial ROS production in the pathogenesis of diabetes mellitus and its complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

The role of oxidative stress in diabetic vascular and neural disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Brain-derived neurotrophic factor (BDNF) and type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Memantine treatment reverses anhedonia, normalizes corticosterone levels and increases BDNF levels in the prefrontal cortex induced by chronic mild stress in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Effects of acute and chronic treatment elicited by lamotrigine on behavior, energy metabolism, neurotrophins and signaling cascades in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Predictors of incident major depression in diabetic outpatients with subthreshold depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Imipramine treatment reverses depressive-like behavior in alloxan-diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Increased prevalence of type 2 diabetes mellitus among psychiatric inpatients with bipolar I affective and schizoaffective disorders independent of psychotropic drug use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Physical activity, a key factor to quality of life in type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

A cross-sectional survey of depression, anxiety, and cognitive function in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Depression and poor glycemic control: a meta-analytic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Does diabetes double the risk of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Examining a bidirectional association between depressive symptoms and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Fall and balance outcomes after an intervention to promote leg strength, balance, and walking in people with diabetic peripheral neuropathy: "feet first" randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Depression and coronary heart disease in women with diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Depression and risk of heart failure among older persons with isolated systolic hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Co-morbid cardiovascular disease and depression: sequence of disease onset is linked to mental but not physical self-rated health. Results from a cross-sectional, population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Depression, glycemic control and type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Independent factors associated with depression in type 1 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Are psychopathological features relevant predictors of glucose control in patients with type 2 diabetes? A prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Suicide attempts and ideation in African-American type 1 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Quality of life and suicide risk in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Effects of aerobic exercise on selected physiological parameters and quality of life in patients with type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

A psychological support program for individuals with Type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Psychological adjustment to diabetes mellitus: highlighting self-integration and self-regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

A prospective study of the role of depression in the development and persistence of adolescent obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Long-term use of antidepressants for depressive disorders and the risk of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Bioinformatics analysis of functional protein sequences reveals a role for brain-derived neurotrophic factor in obesity and type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

Lower extremity muscle strength is reduced in people with type 2 diabetes, with and without polyneuropathy, and is associated with impaired mobility and reduced quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0435-9

10.1007/S00592-012-0435-9

21 January 2018

Identifiers

DOI

1 reference

2 December 2017

1 reference